The EGAPP Working Group was established in 2005 to support the development of a systematic process for assessing the available evidence regarding the validity and utility of rapidly emerging genetic tests for clinical practice.  This independent, multidisciplinary panel prioritizes and selects tests, reviews CDC-commissioned evidence reports and other contextual factors, highlights critical knowledge gaps, and provides guidance on appropriate use of genetic tests in specific clinical scenarios.

 

Nominations for EGAPP Working Group membership are accepted on a continuous basis.

 

  arrow What's New

  • The last EWG meeting was held on September 10 and 11, 2012.
  • Two new members of the EGAPP Working Group, with experience and expertise in pharmacogenomics and public health, will be selected in 2012. Nominate yourself or someone you know today!

more 

  arrow EGAPP Recommendations

 

 

 

Links to organizations are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by EGAPP, and none should be inferred. EGAPP is not responsible for the content of the individual organization Web pages found at these links.

Page last updated: September 14, 2012
Page last reviewed: May 18, 2012
Content Source: EGAPP Team